| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.18B | $901.5M | $2.98B |
| YoY Revenue Growth % | +31.4% | -69.7% | — |
| Gross Profit | $196.3M | -$877.2M | — |
| Gross Margin % | 16.6% | -50.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$301.7M | -$1.71B | $40.2M |
| Operating Margin % | -25.5% | -80.0% | 1.4% |
| Net Income (GAAP) | -$405.4M | -$1.81B | $34.3M |
| EBITDA (Normalized) | -$282.9M | -$1.62B | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $104.3M | -$313.3M | -$180.1M |
| Capital Expenditures (CapEx) | $23.5M | $108.2M | — |
| Free Cash Flow (FCF) | $80.8M | -$421.5M | -$180.1M |
| FCF Margin % | 6.8% | -46.8% | -6.1% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $455.1M | $274.6M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $427.5M | $658.3M | — |